Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FIGO Stages III and IV”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Study completedNCT03054909
What this trial is testing

IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer

Who this might be right for
FIGO Stage III and IV Ovarian CancerFIGO Stage III and IV Fallopian Tube CancerFIGO Stage III Primary Peritoneal Cancer
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)UnknownNCT06377267
What this trial is testing

Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)

Who this might be right for
Ovarian Cancer
Vall d'Hebron Institute of Oncology 100
Large-scale testing (Phase 3)Study completedNCT00052468
What this trial is testing

Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian Cancer
AGO Study Group 1,742
Large-scale testing (Phase 3)Ended earlyNCT01493505
What this trial is testing

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cancer
Amgen 1,015
Large-scale testing (Phase 3)Active Not RecruitingNCT01844986
What this trial is testing

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Who this might be right for
Newly DiagnosedAdvanced Ovarian CancerFIGO Stage III-IV+4 more
AstraZeneca 450
Large-scale testing (Phase 3)Study completedNCT00006454
What this trial is testing

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian Cancer
AGO Study Group
Testing effectiveness (Phase 2)Study completedNCT02713386
What this trial is testing

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous Adenocarcinoma+23 more
NRG Oncology 147
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938583
What this trial is testing

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer by FIGO StageOvarian Cancer Stage IIIOvarian Cancer Stage IV
CanariaBio Inc. 54
Testing effectiveness (Phase 2)Study completedNCT00880360
What this trial is testing

A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 19
Large-scale testing (Phase 3)Study completedNCT02477644
What this trial is testing

Platine, Avastin and OLAparib in 1st Line

Who this might be right for
Ovarian Cancer
Arcagy Research 806
Not applicableActive Not RecruitingNCT04574635
What this trial is testing

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Who this might be right for
Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more
Mayo Clinic 18
Not applicableStudy completedNCT07567573
What this trial is testing

Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery

Who this might be right for
D010051Ovarian CancerAdvanced-stage Ovarian Cancer+2 more
European Society of Gynaecological Oncology 11,383
Large-scale testing (Phase 3)Looking for participantsNCT06580314
What this trial is testing

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaFallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor+9 more
NRG Oncology 880
Early research (Phase 1)Active Not RecruitingNCT01970722
What this trial is testing

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Who this might be right for
FIGO Stage IVA Ovarian CancerFIGO Stage IVB Ovarian CancerPlatinum-Resistant Ovarian Carcinoma+26 more
City of Hope Medical Center 40
Not applicableNot Yet RecruitingNCT07771400
What this trial is testing

Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients

Who this might be right for
Ovarian Cancer by FIGO StageOvarian Cancer Stage IIIOvarian Cancer Stage IV+3 more
Latin American Cooperative Oncology Group 320
Not applicableStudy completedNCT04532645
What this trial is testing

Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

Who this might be right for
Ovary Cancer
AstraZeneca 342
Testing effectiveness (Phase 2)Looking for participantsNCT05284552
What this trial is testing

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
University Hospital, Linkoeping 40
Testing effectiveness (Phase 2)Study completedNCT00490711
What this trial is testing

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Eli Lilly and Company 7
Testing effectiveness (Phase 2)Study completedNCT01097746
What this trial is testing

First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+24 more
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT01773889
What this trial is testing

A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 2
Next Page